EP3630114
Mígalastat til meðhöndlunar á sjúklingum með Fabrys-sjúkdóm sem hafa nýrnaskerðingu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.5.2018EP published:
1.11.2023EP application number:
18733415.6
EP translation filed:
22.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
29.5.2038Expiry date:
29.5.2026Next due date:
31.5.2026
Title in English:
MIGALASTAT FOR TREATING FABRY PATIENTS HAVING RENAL IMPAIRMENTLanguage of the patent:
English
Timeline
Today
30.5.2018EP application
1.11.2023EP Publication
22.1.2024Translation submitted
15.2.2024Registration published
29.5.2026Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
CASTELLI, JeffAddress:
Cranbury, New Jersey 08512, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762512458 PDate:
30.5.2017Country:
US
Number:
201862626953 PDate:
6.2.2018Country:
US
Classification
Categories:
A61K 31/445, A61P 13/12
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.4.2024
Expires: 29.5.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.5.2025
Expires: 29.5.2026
Payer: Árnason Faktor ehf.